local_hospital

Siteworks GmbH

Address
lock Available on a paid plan

Respiratory and Sleep-Related Disorders

At Siteworks GmbH in Hanover, a strong share of the research focuses on respiratory tract diseases and sleep-related conditions. The studies include asthma, chronic obstructive pulmonary disease, refractory chronic cough, and obstructive sleep apnea, with the aim of improving symptom control, lung function, breathing-related outcomes, and overall quality of life.

  • Testing new approaches for inadequately controlled asthma and severe asthma
  • Evaluating treatments for COPD and reducing exacerbations
  • Studying therapies for obstructive sleep apnea linked to overweight or obesity
  • Assessing options for chronic cough and nasal allergy symptoms

This area of research is centered on finding better ways to manage long-term breathing disorders and sleep disturbances.

Pain, Musculoskeletal, and Metabolic Research

Another major theme at the site is the study of pain disorders, musculoskeletal diseases, and nutritional and metabolic diseases. Trials are looking at diabetic peripheral neuropathic pain, knee osteoarthritis, chronic low back pain, hypercholesterolemia, obesity, and related conditions, with the goal of easing pain, supporting mobility, and improving metabolic health.

  • Exploring new therapies for neuropathic pain and osteoarthritis
  • Evaluating treatments for overweight and obesity with related health risks
  • Studying options that may improve cholesterol and cardiovascular risk factors
  • Assessing relief strategies for chronic back pain and joint pain

The research reflects a broader effort to address conditions that commonly affect daily function and long-term health.

Cardiovascular, Kidney, and Blood Pressure Studies

The site also conducts trials in cardiovascular diseases and kidney-related conditions, especially where blood pressure control and heart protection are important. Current research includes uncontrolled hypertension, resistant hypertension, chronic kidney disease, and prevention of heart failure, with studies designed to evaluate better treatment effectiveness and long-term outcomes.

  • Investigating therapies for high blood pressure that remains difficult to control
  • Assessing approaches for chronic kidney disease linked with hypertension
  • Studying prevention of heart failure and cardiovascular complications
  • Comparing treatments to improve LDL cholesterol and cardiovascular risk

These studies aim to support better management of conditions that can lead to serious heart and kidney complications.

Skin, Allergy, and Immune-Mediated Conditions

A notable part of the portfolio addresses skin and connective tissue diseases and immune system diseases. Research at the site includes atopic dermatitis, plaque psoriasis, chronic spontaneous urticaria, perennial allergic rhinitis, and female androgenetic alopecia, focusing on symptom reduction, disease control, and improved patient comfort.

  • Testing new treatments for psoriasis and atopic dermatitis
  • Evaluating therapies for urticaria and allergic rhinitis
  • Studying options for hair loss in women
  • Assessing immune-targeted therapies for persistent inflammatory conditions

This work reflects a strong interest in conditions driven by inflammation, allergy, and immune dysregulation.

Digestive, Hormonal, and Mental Health Research

The remaining studies cover digestive system diseases, hormonal diseases, and mental disorders. Trials include irritable bowel syndrome, diarrhoea-predominant IBS, sleep disturbances associated with menopause, insomnia disorder, and major depressive disorder, with the purpose of improving symptoms, supporting sleep, and evaluating overall treatment benefit.

  • Assessing therapies for IBS and diarrhoea-predominant IBS
  • Studying treatments for menopause-related sleep problems and insomnia
  • Evaluating options for mild to moderate depression
  • Testing supportive approaches for digestive comfort and symptom relief

Together, these studies show a broad interest in conditions that affect sleep, mood, and gastrointestinal health.

Viral and Preventive Medicine

Virus diseases are represented through research on influenza, where the focus is on preventive care and protection against infection. These studies are designed to assess vaccine effectiveness and safety, contributing to better seasonal disease prevention.

  • Evaluating an influenza vaccine for protection against common viral strains
  • Studying safety and immune response in preventive research

This adds a public-health-oriented dimension to the broader clinical trial program at the site.

Site Overview

assignment
36
connected trials
corporate_fare
23
sponsors
science
52
IMPs

Activity Indicator

Last 6 months

2
Trials started
-50% vs previous period.
4
Trials started 6–12 months ago
36
Total trials linked
Highly Active
trending_downDeclining-50%
2
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 4 of 12 therapeutic areas and 15 of 52 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years

Top 40 of 51 compounds, ranked by number of trials.

lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
11
Sponsors (total)
23
Active sponsors
7

Sponsor Network

Top 7 by active trials.

lock +6 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +4 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
36
Outperforms 94% of sites
public
Therapeutic diversity
13areas
Outperforms 98% of sites
groups
Sponsor diversity
23sponsors
Outperforms 94% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Siteworks GmbH

lock Showing 1 of 36 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Double Blind, Multicentre, Randomised Three-Period, Three-Treatment, Cross-Over Study To Evaluate The Effect of BGF MDI, BFF MDI and Placebo MDI on Exercise Parameters In Participants with Chronic Obstructive Pulmonary Disease (ATHLOS)AstraZeneca ABPhase INot RecruitingOct 2023Jan 2026

IMP list

lock Showing 1 of 52 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Budesonide4Unknown2021-04-252024-07-04

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.